Skip to main content
BrainCited

Melatonin for Sleep-Related Cognitive Impairment

C

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dsleep\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

The Bottom Line

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Key Study Findings

review
Pediatric Insomnia.
Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) vs: Placebo Effect: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None
Other
Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin …
Dose: None vs: PCPA-induced insomnia model control Outcome: Sleep quality and cognitive function in rat model Effect: None None

Population: PCPA-induced insomnia male rats

Randomized Controlled Trial n=322 5 weeks Double-blind
Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, …
Dose: 20 mg or 50 mg tasimelteon daily vs: Placebo Outcome: Latency to persistent sleep (PSG) Effect: -44.9 min (20mg) / -46.3 min (50mg) vs -28.2 (placebo) <0.001

Population: Patients with primary insomnia (sleep onset difficulty)

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management Effect: None None

Population: Patients with irregular sleep-wake rhythm disorder

review
Insomnia in older adults: A review of treatment options.
Dose: various vs: Placebo Effect: None None
Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None vs: None Outcome: Pain outcomes Effect: None None

Population: Insomnia patients

Key Statistics

15

Studies

2000

Participants

Positive

C

Grade

Referenced Papers

Pediatrics in review 2026
Cleveland Clinic journal … 2025 12 citations
Current opinion in … 2024 12 citations
La Revue du … 2024
Progress in neuro-psychopharmacology … 2021 68 citations
Neurotherapeutics : the … 2020 80 citations
Current treatment options … 2020 29 citations
Human brain mapping 2020 15 citations
Dermatitis : contact, … 2019 7 citations
Journal of sleep … 2017 1691 citations
Neurological research 2017 331 citations
Nutrients 2017 301 citations
Current treatment options … 2017 56 citations
Clinical therapeutics 2016 328 citations
Chest 2016 109 citations
European heart journal. … 2016 77 citations
Diabetes, obesity & … 2015 132 citations
Pharmacological reports : … 2011 99 citations
Tidsskrift for den … 2006

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
0.5-5 mg/day
sleepcognitivesupport:
0.5-3 mg 30-60 min before bed

Upper limit: 10 mg/day (higher doses not more effective)

Dosages Studied in Research

Dosage Duration Effect N
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) -- Positive --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322
None -- Mixed --
various -- Positive --
None -- Neutral --
None -- Positive 6528
Z-drugs, melatonin, orexin antagonists -- Positive --

Best taken: 30-60 minutes before bedtime

Safety & Side Effects

Reported Side Effects

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams

Known Interactions

  • Sedative medications (additive drowsiness)
  • Blood thinners (may increase bleeding risk)
  • Diabetes medications (may affect blood sugar)
  • Immunosuppressants (may stimulate immune function)
  • Oral contraceptives (may increase melatonin levels)

Tolerable upper intake: 10 mg/day (higher doses not more effective)

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Melatonin help with Sleep-Related Cognitive Impairment?
Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).
How much Melatonin should I take for Sleep-Related Cognitive Impairment?
Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?
We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Other ingredients for Sleep-Related Cognitive Impairment

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.